SCHEMBL2364767

SCHEMBL2364767

CNC(=O)Oc1ccc2c(c1)CCN(C(=O)C(F)(F)F)CC2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.60
▸ ESR2 Q92731 3/20 0.60
▸ ACHE P22303 11/20 0.48
▸ ABHD6 Q9BV23 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ BCHE P06276 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ OPRM1 P35372 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2309023 0.83 ESR1 (0.85) ESR1ESR2ABHD6HDAC6
SCHEMBL5566351 0.78 ACHE (0.52) ACHESMN1; SMN2BCHEKDM4EALDH1A1
SCHEMBL11667483 0.78 POLB (0.52) ACHESMN1; SMN2KDM4EALDH1A1
SCHEMBL31164691 0.75 ESR1 (0.90) ESR1ESR2ABHD6PKM
SCHEMBL3895230 0.75 ESR1 (1.00) ESR1ESR2ABHD6HDAC6
SCHEMBL13334504 0.74 ESR1 (0.56) ESR1ESR2ABHD6SMN1; SMN2KDM4E
SCHEMBL373697 0.74 ESR2 (0.83) ESR1ESR2ABHD6HDAC6
SCHEMBL7854911 0.74 ESR1 (0.70) ESR1ESR2ABHD6PKMHRH3
SCHEMBL1787035 0.73 ESR1 (0.56) ESR1ESR2ABHD6HDAC6SMN1; SMN2
SCHEMBL2675095 0.73 ESR1 (0.61) ESR1ESR2ABHD6PKMHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011083315-A1 COMPOUNDS AND THEIR USE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-07-14 — — WO disclosed
Send feedback